The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Professional Services Scientific, Architectural And Engineering Technical Activities Scientific Research And Development 72 - Scientific research and development
200 jobs Number of planned job creations
Announcement Date
21 April 2016
Employment effect (start)
21 April 2016
Foreseen end date
21 April 2021
Description
Medical product development company Eirgen Pharma plans to hire 200 people over the next five years. The firm, based in Co Waterford, was established in 2005 and was acquired by OPKO Health in 2015. The new roles are described as being "highly-skilled". The existing manufacturing facility in Westside Business Park is to expand, as well as the establishment of an R&D Centre with manufacturing capabilities for new sterile fill finish and dry powder inhalation products. IDA Ireland is supporting the Eirgen Pharma expansion.
Sources
21 April 2016: RTE
21 April 2016: The Irish Times
22 April 2016: Silicon Republic.com
Citation
Eurofound (2016), Eirgen Pharma, Business expansion in Ireland, factsheet number 87294, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/87294.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
